跳至主要内容
临床试验/ACTRN12609000713291
ACTRN12609000713291终止未知

Cerebral palsy and electrical stimulation - does stimulation of the gastrocnemius muscle pre- and post-botulinum toxin A injection for dynamic equinus facilitate greater uptake of the toxin when measured by clinical examination and 3-D gait analysis?

Women's and Children's Hospital0 个研究点目标入组 50 人开始时间: 2009年8月18日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
4 Years 至 12 Years(—)
性别
All

入选标准

  • 1. Children between the ages of 4 and 12 years with a confirmed diagnosis of spastic hemiplegic or spastic diplegic cerebral palsy (CP)
  • 2. Planned injection of gastrocnemius muscle for the treatment of dynamic equinus deformity
  • 3. Walking ability described by classification at Gross Motor Functional Classification System (GMFCS) levels one to three (walks independently or with assistive devices)
  • 4. Ongoing participation in a community-based therapy programme.

排除标准

  • 1. Previous lower limb surgery involving the calf and/or hamstring
  • 2. Use of botox A in the calf muscle within the last six months
  • 3. Inability to follow a single stage command
  • 4. Inability to walk along a 10m walk way for a total of five trials
  • 5. Presence of fixed muscle contractures.
  • 6. Casting post-botox injection

研究者

发起方
Women's and Children's Hospital

相似试验